FDA official logo
GSRS logoPFDA official logo

CAMIDANLUMAB TESIRINE

UNII:LYJ1AEJ9YH
Formula:
Preferred Substance Name:CAMIDANLUMAB TESIRINE

  • 1853239-04-9
  • ADCT301
  • ADCT-301
  • CAMIDANLUMAB TESIRINE [INN]
  • CAMIDANLUMAB TESIRINE [USAN]
  • CAMIDANLUMAB TESIRINE [WHO-DD]
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 2 RECEPTOR .ALPHA. CHAIN)(HUMAN HUMAX-TAC HEAVY CHAIN), HUMAN HUMAX-TAC LIGHT CHAIN, DIMER, THIOETHER WITH N-(31-(2,5-DIHYDRO-2,5-DIOXO-1H-PYRROL-1-YL)-1,29-DIOXO-4,7,10,13,16,19,22,25-OCTAOXA-28-AZAHENTRIACONT-1-YL)-L-VALYL-N-(4-(((((11S,11AS)-8-((5-(((11AS)-5,11A-DIHYDRO-7-METHOXY-2-METHYL-5-OXO-1H-PYRROLO(2,1-C)(1,4)BENZODIAZEPIN-8-YL)OXY)PENTYL)OXY)-11,11A-DIHYDRO-11-HYDROXY-7-METHOXY-2-METHYL-5-OXO-1H-PYRROLO(2,1-C)(1,4)BENZODIAZEPINE-10(5H)-YL)CARBONYL)OXY)METHYL)PHENYL)-L-ALANINAMIDE
  • IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS INTERLEUKIN-2 RECEPTOR SUBUNIT ALPHA (TAC ANTIGEN, P55, CD25 ANTIGEN)), HOMO SAPIENS MONOCLONAL ANTIBODY CONJUGATED TO AN AVERAGE OF TWO MOLECULES OF TESIRINE.GAMMA.1 HEAVY CHAIN (1-445) (HOMO SAPIENS VH (IGHV1-69*02 (95%) (IGHD)-IGHJ4*01 (93%)) (8.8.8) (1-115) -HOMO SAPIENS IGHG1*03 (116-445)), (218-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (HOMO SAPIENS V-KAPPA (IGKV3-20*01 (99%) IGKJ4*01)(6.3.9) (1'-107') -HOMO SAPIENS IGKC*01 (108'-214'))DIMER (224-224'':227-227'')-BISDISULFIDE, AN AVERAGE OF TWO CYSTEINES ARE S-LINKED TO (111AS,911S,911AS,16S,19S,523RS)-911-HYDROXY-17, 97-DIMETHOXY-12,92,16-TRIMETHYL-15,95,10,15,18,21,49,522-525-NONAOXO-19-(PROPAN-2-YL)-15,111A,911,911A-TETRAHYDRO-11H,91H,95H-2,8,11,24,27,30,33,36,39,42,45-UNDECAOXA-14,17,20,48-TETRAAZA-1(8),9(8,10)-BIS(PYRROLO(2,1-C)(1,4)BENZODIAZEPINE)-52(1)-PYRROLIDINA-13(1,4)BENZENADOPENTACONTAPHAN-523-YL




UNII - LYJ1AEJ9YH | UNII Search Service